Vapotherm, Inc. (VAPO)

1.2660 +0.0060 (+0.48%) At close: 01:59PM EDT

Vapotherm, Inc.

100 Domain Drive
Exeter, NH 03833
United States
603 658 0011
https://www.vapotherm.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 182

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Joseph F. Army CPA	CEO, President & Director	575k	N/A	1964
Mr. John Landry	Senior VP, CFO & Treasurer	593.38k	N/A	1973
Mr. Brian Lawrence	Senior VP & CTO	587.13k	N/A	1970
Mr. William Niland	Founder	N/A	N/A	N/A
Ms. Dorota Mckay	VP, Controller & Chief Accounting Officer	N/A	N/A	1983
Mr. Anthony Ten Haagen	Vice President of Legal & Compliance	N/A	N/A	N/A
Mr. James A. Lightman	Senior VP, General Counsel & Secretary	N/A	N/A	1958
Ms. Lindsay Becker	Vice President of Human Resources	N/A	N/A	1985
Dr. Jessica Whittle M.D., Ph.D.	Chief Medical Officer & VP of Clinical Research	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Corporate governance

Vapotherm, Inc.’s ISS governance QualityScore as of 1 April 2024 is 7. The pillar scores are Audit: 8; Board: 6; Shareholder rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.